Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial

BACKGROUND: This study characterises molecular effect of bevacizumab, and explores the relation of molecular and genetic markers with response to bevacizumab combined with chemoradiotherapy (CRT). METHODS: From a subset of 59 patients of 84 rectal cancer patients included in a phase II study combini...

Descripción completa

Detalles Bibliográficos
Autores principales: Verstraete, M, Debucquoy, A, Dekervel, J, van Pelt, J, Verslype, C, Devos, E, Chiritescu, G, Dumon, K, D'Hoore, A, Gevaert, O, Sagaert, X, Van Cutsem, E, Haustermans, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402460/
https://www.ncbi.nlm.nih.gov/pubmed/25867261
http://dx.doi.org/10.1038/bjc.2015.93

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402460/
https://www.ncbi.nlm.nih.gov/pubmed/25867261
http://dx.doi.org/10.1038/bjc.2015.93

Ejemplares similares